Isla Technologies

Founded in 2019 and headquartered in San Carlos, California, Isla Technologies is a medical device startup dedicated to addressing the challenges of type 1 diabetes. The company's core mission is to develop innovative, minimally invasive cell implants that can autonomously secrete insulin, thereby helping patients achieve better glucose control. Isla Technologies aims to improve the quality of life for the over 1.6 million Americans and 21 million people worldwide affected by this autoimmune disease.

Isla Technologies has garnered attention for its groundbreaking approach to diabetes treatment, attracting notable investors and experts in the medical field. The company has achieved significant milestones in its research and development efforts, positioning itself as a leader in the medical device industry. By focusing on a minimally invasive solution, Isla Technologies is poised to make a substantial impact on the management of type 1 diabetes, offering hope to millions of patients globally.